Why did B8F.DE stock spike in volume today?

Volume jumped to **45,797** vs avg **605**, likely from large blocks, short-covering or a liquidity event in a thinly traded small-cap. No confirmed company news was published at close; monitor official releases and trading updates for a clear driver.

What valuation metrics matter for B8F.DE stock?

Key metrics: EPS **-0.21**, P/E **-32.40**, price-to-sales **0.64**, price-to-book **21.73**, and current ratio **1.76**. Compare these with peer healthcare averages before taking a position.

What is Meyka AI’s 12‑month forecast for B8F.DE stock?

Meyka AI's forecast model projects a base case of **€9.00**, a bull case of **€12.00** and a bear case of **€4.00**, implying a **32.35%** upside from **€6.80**. Forecasts are model-based projections and not guarantees.

Should I trade B8F.DE stock after the spike?

For traders use tight execution: limit orders, small size and stop levels. For investors, await confirmation via company updates or sustained volume before adding exposure due to elevated volatility and liquidity risk.

DE Stocks

B8F.DE stock up to €6.80 on 75x volume: liquidity spike to watch 30 Jan 2026

ByHuzaifa Zahoor January 31, 2026

B8F.DE stock closed at €6.80 on XETRA on 30 Jan 2026 after a dramatic intraday move driven by outsized volume. Trading volume hit 45,797 shares versus an average of 605, a relative volume of 75.70x, marking the session as a clear high-volume mover. The price opened at €0.37, touched a low of €0.30 then ran to the session high of €6.80. We review what pushed Biofrontera AG (B8F.DE) higher, connect the flow to fundamentals and technicals, and provide Meyka AI’s model forecast and grade for investors in Germany’s healthcare sector.